Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,681 to 1,700 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress and prospects in human genetic research into age-related hearing impairment. | Biomed Res Int | 2014 | 25140308 | PubTator, text mining | PubMed |
| Novel NAT2 haplotyping using allele-specific sequencing. | Pharmacogenomics | 2014 | 25084204 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis. | Asian Pac J Cancer Prev | 2014 | 25081676 | PubTator, text mining | PubMed |
| Clinical translation in the virtual liver network. | CPT Pharmacometrics Syst Pharmacol | 2014 | 25076067 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis. | Tumour Biol | 2014 | 25051916 | PubTator, text mining | PubMed |
| Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. | Hum Psychopharmacol | 2014 | 25042870 | PubTator, text mining | PubMed |
| Deciphering next-generation pharmacogenomics: an information technology perspective. | Open Biol | 2014 | 25030607 | PubTator, text mining | PubMed |
| N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. | Med Oncol | 2014 | 25005845 | PubTator, text mining | PubMed |
| Integrated multidimensional analysis is required for accurate prognostic biomarkers in colorectal cancer. | PLoS One | 2014 | 24988459 | PubTator, text mining | PubMed |
| Large-scale proteome quantification of hepatocellular carcinoma tissues by a three-dimensional liquid chromatography strategy integrated with sample preparation. | J Proteome Res | 2014 | 24972180 | PubTator, text mining | PubMed |
| Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake. | Cancer Epidemiol | 2014 | 24950597 | PubTator, text mining | PubMed |
| Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases. | Pharmacol Rep | 2014 | 24948072 | PubTator, text mining | PubMed |
| CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients. | Med Oncol | 2014 | 24939416 | PubTator, text mining | PubMed |
| GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. | Diabetologia | 2014 | 24934506 | PubTator, text mining | PubMed |
| Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction. | Mol Biol Rep | 2014 | 24934312 | PubTator, text mining | PubMed |
| Synergism between the N-acetyltransferase 2 gene and oxidant exposure increases the risk of idiopathic male infertility. | Reprod Biomed Online | 2014 | 24928356 | PubTator, text mining | PubMed |
| NAT2, XRCC1 and hOGG1 polymorphisms, cigarette smoking, alcohol consumption and risk of upper aerodigestive tract cancer. | Anticancer Res | 2014 | 24922697 | PubTator, text mining | PubMed |
| Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches. | Int J Mol Sci | 2014 | 24918288 | PubTator, text mining | PubMed |
| Cotrimoxazole - optimal dosing in the critically ill. | Ann Intensive Care | 2014 | 24910807 | PubTator, text mining | PubMed |
| A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? | Curr Drug Metab | 2014 | 24909419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=85